SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-000328
Filing Date
2015-01-05
Accepted
2015-01-05 13:51:35
Documents
2
Period of Report
2015-01-01

Document Format Files

Seq Description Document Type Size
1 form333091_20150105015026-.html 3  
1 form333091_20150105015026-.xml 3 2762
2 ex-24.htm EX-24 3122
  Complete submission text file 0001144204-15-000328.txt   7352
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017-7550
Business Address
Klima Thomas J (Reporting) CIK: 0001629278 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35076 | Film No.: 15503692